Why is Ajanta Pharma falling/rising?

As of 25-Sep, Ajanta Pharma Ltd. is experiencing a decline in its stock price, currently at Rs 2,487.80, reflecting a decrease of Rs 42.45 or 1.68%. The stock has underperformed its sector by 0.82% today and has been on a consecutive downward trend for the last two days, accumulating a total decline of 2.16%. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, Ajanta Pharma has seen a return of -2.44%, and over the past month, it has dropped by 5.05%, significantly underperforming the benchmark Sensex, which has only decreased by 2.23% in the same timeframe. Despite some positive indicators such as high management efficiency and strong institutional holdings, the stock's long-term growth prospects appear poor, with net sales and operating profit growing at only 12.69% and 12.12% annually over the last five years, respectively.
In the broader market context, Ajanta Pharma's performance has been notably weaker than the benchmark, with a year-to-date return of -15.55% compared to the Sensex's positive return of 3.87%. This stark contrast highlights the stock's struggles in a generally recovering market. The company's recent financial performance, while showing some positive results, has not translated into investor confidence, as evidenced by the significant drop in stock price and the high PEG ratio of 3.4, indicating an expensive valuation relative to its growth. Overall, the combination of poor long-term growth prospects, recent underperformance, and high valuation concerns are contributing to the stock's decline.